Jaime-Pérez JC

Language: Spanish
References: 10
Page: 119-120
PDF size: 58.82 Kb.

Text Extraction

No abstract

REFERENCES

1. Ablain J, de The H. Revisiting the differentiation paradigm in acute promyelocytic leukemia. Blood 2011;117:5795-5802.

2. Ghavamzadeh A, Alimoghaddam K, Rostami S, Ghaffari SH, et al. Phase II study of single-agent arsenic trioxide for the front-line therapy of acute promyelocytic leukemia. J Clin Oncol 2011;29:2753-2757.

3. Sanz MA, Lo-Coco F. Modern approaches to treating acute promyelocytic leukemia. Clin Oncol 2011;29:495-503.

4. Park JH, Tallman MS. Managing acute promyelocytic leukemia without conventional chemotherapy: is it possible? Expert Rev Hematol 2011;4:427-36

5. Douer D. The epidemiology of acute promyelocytic leukemia. Best Pract Res Haematol 2003;16(3):357-367.

6. Ruiz-Arguelles GJ, Morales-Torquero A, Gómez-Rangel JD, López-Martínez B, et al. Treatment of acute promyelocytic leukemia: a single institution experience. Rev Inv Clin 2005;57:415-419.

7. Gómez-Guijosa MA, Gutiérrez-Aguirre CH, Cantú-Rodríguez OG, Heredia Salazar AC, Gómez-Almaguer D. Leucemia promielocítica aguda. Resultados del tratamiento en el Hospital Universitario de la UANL, Monterrey. Medicina Univ 2009;11:165-169.

8. Rego EM, Kim HT, Ruiz-Arguelles GJ, et al. Improving the treatment outcome of acute promyelocytic leukemia in developing countries through international cooperative network. Report of the International Consortium on Acute Promyelocytic Leukemia study group. Blood 2009;114-115.

9. Ramos-Peñafiel CH, Montaño-Figueroa E, Martínez-Tovar A, et al. Experiencia del tratamiento de la leucemia aguda promielocítica en una institución de la Ciudad de México. Rev Hematol Mex 2011;12(3):125-130.

10. De León-Cantú RE, Carrizales-Villarreal JA, Ceballos-López AA, Gómez-Almaguer D. Leucemia promielocítica con infiltración meníngea. Presentación de cuatro casos clínicos. Rev Hematol Mex 2011;12(3):140-143.